NAFLD hepatic tissues and FFA-treated HepG2 and Huh-7 cells presented miR-122 upregulation, which was found able to suppress Sirt1 expression via binding to its 3′-untranslated region (UTR) [36]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.